ctrl K

Price Alert

Akari Therapeutics (AKTX)

NASDAQ: AKTX · Real-Time Price · USD

1.00

0.03 (3.08%)

At close: Aug 15, 2025, 3:58 PM

1.00

0.00%

After-hours: Aug 15, 2025, 04:10 PM EDT

Akari Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.6M	3.85M	13.25M	9.36M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	0.00
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	-2.49M	n/a
Other Current Assets	353K	197K	99.54K	90.3K
Total Current Assets	2.95M	4.34M	13.81M	11.63M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	47.61M	14K	16.88K	22.93K
Total Long-Term Assets	47.61M	14K	16.88K	22.93K
Total Assets	50.56M	4.36M	13.83M	11.65M
Account Payables	12.41M	1.67M	947K	1.79M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	3.26M	n/a	n/a	n/a
Other Current Liabilities	4.24M	2.73M	7.95M	1.12M
Total Current Liabilities	19.91M	4.58M	12.04M	6.09M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	383K	n/a	n/a	n/a
Total Long-Term Liabilities	8.42M	n/a	946.66K	4.3M
Total Liabilities	28.33M	4.58M	12.04M	6.09M
Total Debt	3.26M	n/a	n/a	n/a
Common Stock	5.32M	1.32M	744.49K	475.97K
Retained Earnings	-247.25M	-227.46M	-217.45M	-199.71M
Comprehensive Income	-738K	51.15M	-770.84K	-540.97K
Shareholders Equity	22.23M	-229K	1.79M	5.55M
Total Investments	n/a	n/a	n/a	n/a